98 reports of this reaction
2.4% of all RILPIVIRINE HYDROCHLORIDE reports
#8 most reported adverse reaction
VIRAL LOAD INCREASED is the #8 most commonly reported adverse reaction for RILPIVIRINE HYDROCHLORIDE, manufactured by Janssen Products, LP. There are 98 FDA adverse event reports linking RILPIVIRINE HYDROCHLORIDE to VIRAL LOAD INCREASED. This represents approximately 2.4% of all 4,147 adverse event reports for this drug.
Patients taking RILPIVIRINE HYDROCHLORIDE who experience viral load increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VIRAL LOAD INCREASED is a less commonly reported adverse event for RILPIVIRINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to viral load increased, the following adverse reactions have been reported for RILPIVIRINE HYDROCHLORIDE:
The following drugs have also been linked to viral load increased in FDA adverse event reports:
VIRAL LOAD INCREASED has been reported as an adverse event in 98 FDA reports for RILPIVIRINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VIRAL LOAD INCREASED accounts for approximately 2.4% of all adverse event reports for RILPIVIRINE HYDROCHLORIDE, making it a notable side effect.
If you experience viral load increased while taking RILPIVIRINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.